High uric acid can make the body feel heavy, tired, and inflamed. Many people link it only with joint pain, but it also affects energy, sleep, and day-to-day comfort. The good news is that small, ...
XORTX Therapeutics Inc. ("XORTX" or the "Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical ...
A new study published in The Journal of Rheumatology showed that despite using lower dosages, febuxostat more successfully ...
Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
Dealbreaker on MSN
Sobi grows its gout drug prospects with $950M acquisition of startup Arthrosi Therapeutics
Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire ...
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused ...
7don MSN
What causes inflammation in the body: Understanding how the body responds, and recommended remedies
Inflammation is often referred to as a single issue, but the fact is, it is a condition that acknowledges the body is dealing ...
Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.
TipRanks on MSN
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing
The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). On December 31, 2025, XORTX Therapeutics highlighted newly published, ...
East Idaho News on MSN
Kidney stones explained: causes, symptoms and how to prevent them
Q: What are kidney stones, and how do I prevent them? Kidney stones are common, impacting approximately one in five men and ...
As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results